Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


CMS Staffs Up, Posts Resources For Upcoming Sunshine Requirements

This article was originally published in The Gray Sheet

Executive Summary

The agency is taking steps to help companies prepare for the new physician payment disclosure mandates, which officials are now referring to as the “Open Payment Program,” while also getting ready to enforce the rules.

You may also be interested in...

News Briefs: CMS Sunshine Rule User Guide; Bard Acquisition; Sapien Japan Reimbursement

CMS releases user guide and manual for companies to comply with the Physician Payments Sunshine Act rule provisions. CR Bard acquires Medafor to add to its Davol surgical specialties unit. More news.

News Briefs: User Fee Bill, Sunshine Mobile Apps, More

The House introduced a bill that would exempt device and drug user fees from sequestration cuts. CMS releases two mobile apps to help track payments required under the Sunshine law. More news.

Companies Dig Into Sunshine Rule Details In Preparation For Aug. 1 Go-Live Date

CMS has finalized several sunshine rule provisions: the definition of “applicable manufacturer” has been narrowed; many payments to speakers at continuing medical education programs and events need not be reported; and the agency will allow manufacturers to supply contextual information on the public database.


Latest Headlines
See All



Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts